Market research

GALDY GALDERMA GROUP AG

NYSE USD Healthcare

Latest close

— —

Loading market data…

Test a moving-average rule with historical data.

Market facts

Market cap: 44B
P/E ratio: 52.26
Analyst target: 50.0194
Dividend yield: 0.2%
Beta: -0.11

Loading price history…

Profile

Company facts

Exchange: NYSE
Currency: USD
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
ISIN: US36321W1053
Market cap: 44B
P/E ratio: 52.26
Analyst target: 50.0194
Dividend yield: 0.2%
Beta: -0.11

About

About GALDERMA GROUP AG

Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.

Visit company website

Reported results

Fundamentals

Open this section to load reported financial history.

Annual returns

No comments yet

Start a focused discussion about GALDY.

GALDY GALDERMA GROUP AG

Price & volume

Company facts

About GALDERMA GROUP AG

Fundamentals

Earnings

Cash flow

Profitability

Valuation

Performance

Annual returns

Investor discussion

No comments yet